Search Within

Gary Schwartz

Formats
  1. Journal Article (191)
  2. Meeting Abstract (190)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (215)
  2. Solid Tumor Oncology Division (205)
  3. Melanoma Disease Management Team (129)
  4. Center for Pancreatic Cancer Research (99)
  5. Gastrointestinal Oncology Service (99)
  6. GSK Faculty (91)

More Groups

People
  1. David Kelsen (79)
  2. Richard Carvajal (61)
  3. Manish Shah (41)
  4. Mark Dickson (40)
  5. Eileen O'Reilly (36)
  6. Monica Motwani (36)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (2)
  4. 2016 (3)
  5. 2015 (5)
  6. 2014 (23)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Cancer Research (42)
  3. Clinical Cancer Research (39)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (30)
  5. Annals of Oncology (12)
  6. Cancer (12)

More Publications

Publishers
  1. American Association for Cancer Research (121)
  2. American Society of Clinical Oncology (105)
  3. Elsevier Inc. (20)
  4. Springer (20)
  5. Oxford University Press (16)
  6. Wiley Blackwell (15)

More Publishers

Results (385)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Journal Article

    Fornier, M. N.; Rathkopf, D.; Shah, M.; Patil, S.; O'reilly, E.; Tse, A. N.; Hudis, C.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1
    Journal Article

    Ambrosini, G.; Sambol, E. B.; Carvajal, D.; Vassilev, L. T.; Singer, S.; Schwartz, G. K.
    Oncogene (2007)

    Fulltext@MSK | Save
  • Disrupting the notch pathway with gamma-secretase inhibitors suppresses growth and induces apoptosis of sarcoma cell lines with constitutively active ras and notch signaling pathways
    Meeting Abstract

    Meng, R. D.; Shelton, C. C.; Li, Y.; Schwartz, G. K.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • beta-Catenin loss-of-function and its putative role as a tumor suppressor to sarcomagenesis
    Meeting Abstract

    Matushansky, I.; Hernando, E.; Singer, S.; Schwartz, G.; Cordon-Cardo, C.; Maki, R.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • The differentiation-related gene-1 (Drg1) inhibits chemotherapy-induced apoptosis by stabilizing Bcl-2 through direct binding
    Meeting Abstract

    Ambrosini, G.; Seelman, S. L.; Schwartz, G. K.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)
    Meeting Abstract

    Shah, M. A.; Ramanathan, R. K.; Ilson, D.; Randazzo, J.; Schwartz, G. K.; Tse, A.; D'adamo, D.; Levner, A.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Randomized phase II trial comparing two paclitaxel (P))-cisplatin (C) containing chemoradiation (CRT) regimens as adjuvant therapy in resected gastric cancer (RTOG 0114)
    Meeting Abstract

    Schwartz, G. K.; Winter, K.; Minsky, B.; Janjan, N.; Schaefer, P.; Thomson, J.; Anne, R.; Gross, H.; Willet, C.; Kelsen, D.
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save
  • A putative tumor suppressor role for Wnt-signaling in sarcomagenesis
    Meeting Abstract

    Matushansky, I.; Socci, N.; Hernando, E.; Singer, S.; Schwartz, G.; Cordon-Cardo, C.; Maki, R.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Ribonucleotide reductase M2 subunit as novel target for liposarcoma
    Meeting Abstract

    Geha, R. C.; Wu, V.; Decarolis, P.; O'Connor, R.; Chen, J.; Schwartz, G.; Singer, S.
    Journal of the American College of Surgeons (2006)

    Fulltext@MSK | Save
  • A phase I trial of doxorubicin and flavopiridol in soft tissue sarcoma
    Meeting Abstract

    D'adamo, D. R.; Scheu, K.; Singer, S.; Schwartz, G. K.; Maki, R. G.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save